Crystal Qin is the founder of LaNova Medicines. LaNova Medicines has raised $42M in total funding. Latest round: Series C. Based in Shanghai, China.
Crystal Qin is the founder, chairwoman, and CEO of LaNova Medicines. She has led the company since its establishment in 2019, focusing on original innovation in immuno-oncology and tumor microenvironment. Under her leadership, LaNova Medicines has developed a robust pipeline of differentiated innovative drugs and is committed to bringing China's innovative drugs to a global stage.
Full founder directory · Investor directory · Company funding database · Fundraising library